Sirolimus (Rapamycin) for Slow-Flow Malformations in Children-Reference-Cited by-同舟云学术

Sirolimus (Rapamycin) for Slow-Flow Malformations in Children

Published:2021-11-01 Issue:11 Volume:157 Page:1289
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Maruani Annabel¹²³,Tavernier Elsa¹³,Boccara Olivia⁴,Mazereeuw-Hautier Juliette⁵,Leducq Sophie¹²,Bessis Didier⁶,Guibaud Laurent⁷,Vabres Pierre⁸,Carmignac Virginie⁸,Mallet Stéphanie⁹,Barbarot Sébastien¹⁰,Chiaverini Christine¹¹,Droitcourt Catherine¹²,Bursztejn Anne-Claire¹³,Lengellé Céline¹⁴,Woillard Jean-Baptiste¹⁵,Herbreteau Denis¹⁶,Le Touze Anne¹⁷,Joly Aline¹⁸,Léauté-Labrèze Christine¹⁹,Powell Julie²⁰,Bourgoin Hélène²¹,Gissot Valérie³,Giraudeau Bruno¹³,Morel Baptiste²²

Affiliation:

1. University of Tours, University of Nantes, Institut National de la Santé et de la Recherche Médicale, SPHERE U1246, Tours, France

2. Centre Hospitalier Régional Universitaire Tours, Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies Génétiques rares à Expression Cutanée–Tours), Tours, France

3. Centre Hospitalier Régional Universitaire Tours, Institut National de la Santé et de la Recherche Médicale Clinical Investigation Center 1415, Tours, France

4. Department of Dermatology and Reference Center for Genodermatoses and Rare Skin Diseases (Maladies Génétiques rares à Expression Cutanée–Necker), University Hospital Necker-Enfants Malades, Paris, France

5. Department of Dermatology, University Hospital Center of Toulouse, Toulouse, France

6. Department of Dermatology, University Hospital Center of Montpellier, Montpellier, France

7. University Hospital Center of Lyon, Consultation Multidisciplinaire Lyonnaise des Angiomes, Lyon, France

8. Department of Dermatology, University Hospital Center of Dijon, Dijon, France

9. Department of Dermatology, University Hospital Center of Marseille, Marseille, France

10. Department of Dermatology, University Hospital Center of Nantes, Nantes, France

11. Department of Dermatology, University Hospital Center of Nice, Nice, France

12. Department of Dermatology, University Hospital Center of Rennes, Rennes, France

13. Department of Dermatology, University Hospital Center of Nancy, Nancy, France

14. Centre Hospitalier Régional Universitaire Tours, Department of Clinical Pharmacology, Regional Pharmacovigilance Center, Tours, France

15. Centre Hospitalier Universitaire Limoges, Department of Pharmacology and Toxicology, University of Limoges, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 850, Limoges, France

16. University of Tours, Centre Hospitalier Régional Universitaire Tours, Department of Neuroradiology, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies Génétiques rares à Expression Cutanée–Tours), Tours, France

17. Centre Hospitalier Régional Universitaire Tours, Department of Pediatric Surgery, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies Génétiques rares à Expression Cutanée–Tours), Tours, France

18. Centre Hospitalier Régional Universitaire Tours, Department of Pediatric Maxillofacial Surgery, Reference Center for Genodermatoses and Rare Skin Diseases (Maladies Génétiques rares à Expression Cutanée–Tours), Tours, France

19. Department of Dermatology, University Hospital Center of Bordeaux, Bordeaux, France

20. Department of Pediatric Dermatology, Hospital Sainte-Justine, Montréal, Québec, Canada

21. Centre Hospitalier Régional Universitaire Tours, Department of Pharmacy, Tours, France

22. University of Tours, Centre Hospitalier Régional Universitaire Tours, Department of Pediatric Radiology, Tours, France

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2784291/jamadermatology_maruani_2021_oi_210047_1636039113.08702.pdf

Reference44 articles.

1. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies.;Wassef;Pediatrics,2015

3. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.;Luks;J Pediatr,2015

4. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS).;Vahidnezhad;Exp Dermatol,2016

5. Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.;Kuentz;Genet Med,2017

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIK3CA-Related Disorders: From Disease Mechanism to Evidence-Based Treatments;Annual Review of Genomics and Human Genetics;2024-08-27

2. Pathophysiology in Brain Arteriovenous Malformations: Focus on Endothelial Dysfunctions and Endothelial-to-Mesenchymal Transition;Biomedicines;2024-08-07

3. Targeted treatments for vascular malformations: current state of the art;Journal of Thrombosis and Haemostasis;2024-08

4. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients;Frontiers in Pediatrics;2024-07-17

5. Sample Size Calculation for an Individual Stepped‐Wedge Randomized Trial;Biometrical Journal;2024-07